FLAM
First Light Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.9M | Buy |
864,136
+8,717
| +1% | +$251K | 3.22% | 11 |
|
|
2025
Q1 | $28.7M | Sell |
855,419
-30,034
| -3% | -$1.01M | 3.28% | 11 |
|
|
2024
Q4 | $45.3M | Sell |
885,453
-58,158
| -6% | -$2.97M | 4.33% | 9 |
|
|
2024
Q3 | $48.2M | Sell |
943,611
-256,897
| -21% | -$13.1M | 4.01% | 7 |
|
|
2024
Q2 | $53.8M | Sell |
1,200,508
-489,669
| -29% | -$21.9M | 4.71% | 3 |
|
|
2024
Q1 | $79.1M | Sell |
1,690,177
-297,595
| -15% | -$13.9M | 6.06% | 1 |
|
|
2023
Q4 | $70.7M | Buy |
1,987,772
+404,443
| +26% | +$14.4M | 5.69% | 4 |
|
|
2023
Q3 | $47.1M | Buy |
1,583,329
+26,107
| +2% | +$776K | 4.47% | 6 |
|
|
2023
Q2 | $28.1M | Sell |
1,557,222
-61,903
| -4% | -$1.12M | 2.2% | 15 |
|
|
2023
Q1 | $26M | Buy |
1,619,125
+289,812
| +22% | +$4.65M | 2.34% | 15 |
|
|
2022
Q4 | $24.3M | Sell |
1,329,313
-17,339
| -1% | -$317K | 2.26% | 16 |
|
|
2022
Q3 | $26.4M | Buy |
1,346,652
+106,043
| +9% | +$2.08M | 2.68% | 13 |
|
|
2022
Q2 | $23.1M | Buy |
1,240,609
+657,842
| +113% | +$12.3M | 2.69% | 13 |
|
|
2022
Q1 | $12.8M | Buy |
582,767
+309,971
| +114% | +$6.8M | 1.13% | 29 |
|
|
2021
Q4 | $7.75M | Buy |
+272,796
| New | +$7.75M | 0.56% | 41 |
|